The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kuz'mina U.Sh.

Institut biohimii i genetiki Ufimskiĭ nauchnyĭ tsentr RAN, Ufa

Zainullina L.F.

Institute of Biochemistry and Genetics Ufa Federal Research Center, Russian Academy of Scienses, Ufa, Russia

Vakhitov V.A.

Institute of Biochemistry and Genetics Ufa Federal Research Center, Russian Academy of Scienses, Ufa, Russia

Bakhtiiarova K.Z.

Bashkirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Ufa

Vahitova Ju.V.

Institut biohimii i genetiki Ufimskiĭ nauchnyĭ tsentr RAN, Ufa

The role of glutamate in the pathogenesis of multiple sclerosis

Authors:

Kuz'mina U.Sh., Zainullina L.F., Vakhitov V.A., Bakhtiiarova K.Z., Vahitova Ju.V.

More about the authors

Views: 2488

Downloaded: 72


To cite this article:

Kuz'mina USh, Zainullina LF, Vakhitov VA, Bakhtiiarova KZ, Vahitova JuV. The role of glutamate in the pathogenesis of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):160‑167. (In Russ.)
https://doi.org/10.17116/jnevro2019119081160

Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119
Biobanking in clinical trials invo­lving multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):7-15
Adhe­rence to treatment in the mana­gement of patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):26-32
Opti­mal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):37-42

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.